Medicated jellies are widely used by a large part of patients, especially by
people with swallowing difficulties. Preformulation studies play an
essential role in the development of new pharmaceutical formulations. The
present study aimed to formulate and evaluate medicated jellies containing
perphenazine, an antipsychotic drug from the group of phenothiazine
compounds used to treat schizophrenia and other mental disorders. Typical
gelling agents such as sodium alginate (Alg), gelatine (Gel), and pectin
(Pec) were used to develop the medicated jellies. In addition to the
biopolymers, components such as benzoic acid (BenzAc), citric acid (CitAc),
sodium citrate (NaCit), sorbitol (Sorb), and xylitol (Xyl) were also used.
Before preparing the jellies, the moist binary mixture between each
component of the jelly and the active substance was analyzed to investigate
the compatibility of the substances. The active substance, moist binary
mixture, and medicated jellies were analyzed by FTIR_UATR spectroscopy,
UV-Vis spectroscopy, and thermogravimetry (TGA).